Novo Nordisk Tokenized Stock (Reality)
RNVO

37.79
$
0.03 %
Change 24h
Market Cap
$ 261,560
Volume 24h
$ 28.67
Circulating Supply
6921
Total Supply
8604
RNVO
$
# Exchange Pair Price Volume 24h

Description

Novo Nordisk is a Denmark-based global healthcare company focused on diabetes, obesity, rare blood disorders and endocrine diseases. Its GLP-1 portfolio gives it a central position in metabolic disease treatment, with growth tied to manufacturing expansion, indication broadening, competition and reimbursement dynamics in major markets.
We Use Cookies
By continuing to use our site, you accept our use of cookies